Clostridium Chauvoei Bacterin Toxoid + Clostridium Novyi Bacterin Toxoid + Clostridium Perfringens Type C Bacterin Toxoid + Clostridium Perfringens Type D Bacterin Toxoid + Clostridium Septicum Bacterin Toxoid + Clostridium Sordellii Bacterin Toxoid

Verify with FDA CVM →

34 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
34
Total Reports
29
Deaths Reported
8530.0%
Death Rate

Active Ingredients

Clostridium Chauvoei Bacterin ToxoidClostridium Novyi Bacterin ToxoidClostridium Perfringens Type C Bacterin ToxoidClostridium Perfringens Type D Bacterin ToxoidClostridium Septicum Bacterin ToxoidClostridium Sordellii Bacterin Toxoid

Administration Routes

UnknownSubcutaneousIntramuscular

Species Affected

Cattle 34

Most Affected Breeds

Cattle (other) 19
Crossbred Bovine/Cattle 6
Cattle (unknown) 4
Aberdeen Angus 3
Charolais 1
Holstein-Friesian also known as Holstein 1

Most Reported Reactions

Death 26
Lack of efficacy - NOS 22
Depression 3
Anorexia 3
Necropsy performed 3
Bloody diarrhoea 2
Fever 2
Death by euthanasia 2
Lack of efficacy (bacteria) - NOS 2
Recumbency 1
NT - necrohemorrhagic enteritis 1
NT - ulcerative colitis 1

Outcome Breakdown

Died
28 (50.0%)
Outcome Unknown
12 (21.4%)
Recovered/Normal
7 (12.5%)
Ongoing
6 (10.7%)
Recovered with Sequela
2 (3.6%)
Euthanized
1 (1.8%)

Data Summary

Metric Value
Total adverse event reports 34
Reports involving death 29
Case-fatality rate (reported events) 8530.0%
Distinct species in reports 1
Distinct breeds in reports 6
Distinct reactions reported 20
Active ingredients on file 6

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Clostridium Chauvoei Bacterin Toxoid + Clostridium Novyi Bacterin Toxoid + Clostridium Perfringens Type C Bacterin Toxoid + Clostridium Perfringens Type D Bacterin Toxoid + Clostridium Septicum Bacterin Toxoid + Clostridium Sordellii Bacterin Toxoid Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 34 adverse event reports referencing Clostridium Chauvoei Bacterin Toxoid + Clostridium Novyi Bacterin Toxoid + Clostridium Perfringens Type C Bacterin Toxoid + Clostridium Perfringens Type D Bacterin Toxoid + Clostridium Septicum Bacterin Toxoid + Clostridium Sordellii Bacterin Toxoid, including 29 reports in which the animal died — a 8530.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Clostridium Chauvoei Bacterin Toxoid, Clostridium Novyi Bacterin Toxoid, Clostridium Perfringens Type C Bacterin Toxoid, Clostridium Perfringens Type D Bacterin Toxoid, Clostridium Septicum Bacterin Toxoid. Reported administration routes include Unknown, Subcutaneous, Intramuscular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Clostridium Chauvoei Bacterin Toxoid + Clostridium Novyi Bacterin Toxoid + Clostridium Perfringens Type C Bacterin Toxoid + Clostridium Perfringens Type D Bacterin Toxoid + Clostridium Septicum Bacterin Toxoid + Clostridium Sordellii Bacterin Toxoid reports are Cattle (34 reports), with Cattle accounting for the largest share. Within those species, Cattle (other) (19), Crossbred Bovine/Cattle (6), Cattle (unknown) (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Clostridium Chauvoei Bacterin Toxoid + Clostridium Novyi Bacterin Toxoid + Clostridium Perfringens Type C Bacterin Toxoid + Clostridium Perfringens Type D Bacterin Toxoid + Clostridium Septicum Bacterin Toxoid + Clostridium Sordellii Bacterin Toxoid are Death (26), Lack of efficacy - NOS (22), Depression (3), Anorexia (3). Of the 56 reports with a coded outcome, Died is the leading category at 50.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Clostridium Chauvoei Bacterin Toxoid + Clostridium Novyi Bacterin Toxoid + Clostridium Perfringens Type C Bacterin Toxoid + Clostridium Perfringens Type D Bacterin Toxoid + Clostridium Septicum Bacterin Toxoid + Clostridium Sordellii Bacterin Toxoid.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial